Articles from Antidepressants

Primary tabs

FDA Approves Nasal Spray for Treatment-Resistant Depression - Everyday Health

Submitted by Anonymous (not verified) on Mon, 03/11/2019 - 19:48

FDA Approves Nasal Spray for Treatment-Resistant Depression  Everyday HealthKetamine-derived drug promises new hope for people who did not benefit from antidepressant medicines.

The FDA approved a new ketamine depression drug — here’s what’s next - The Verge

Submitted by Anonymous (not verified) on Mon, 03/11/2019 - 19:45

The FDA approved a new ketamine depression drug — here’s what’s next  The VergeFor years, ketamine clinics across the country have offered intravenous infusions as a fast-acting treatment for severe depression. But the US Food and Drug ...

Warnings over mental impact of benefit changes must be heeded - The Guardian

Submitted by Anonymous (not verified) on Mon, 03/11/2019 - 18:20

Warnings over mental impact of benefit changes must be heeded  The GuardianLetters: Readers respond to news that the benefits system shake-up is damaging people's mental health and putting increasing strain on the NHS.

8 Reasons Why Your Depression May Not Be Getting Better - PsychCentral.com

Submitted by Anonymous (not verified) on Mon, 03/11/2019 - 16:17

8 Reasons Why Your Depression May Not Be Getting Better  PsychCentral.comYou've been to four psychiatrists and tried over a dozen medication combinations. You still wake up with that dreadful knot in your stomach and wonder if you.

FDA Approves Nasal Spray for Depression - ValdostaToday.com

Submitted by Anonymous (not verified) on Mon, 03/11/2019 - 15:48

FDA Approves Nasal Spray for Depression  ValdostaToday.comThe U.S. Food and Drug Administration approved Spravato (esketamine) nasal spray on March 5, in conjunction with an oral antidepressant, for the treatment of ...

The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's - Nasdaq

Submitted by Anonymous (not verified) on Mon, 03/11/2019 - 15:06

The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's  NasdaqFor Immediate ReleaseChicago, IL - March 11, 2019 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity.

The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's - Nasdaq

Submitted by Anonymous (not verified) on Mon, 03/11/2019 - 15:06

The Zacks Analyst Blog Highlights: J&J, Lilly, Pfizer, AstraZeneca and Merck's  NasdaqFor Immediate Release Chicago, IL - March 11, 2019 - Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity.

What are your thoughts on the use of medical marijuana? - Urology Times

Submitted by Anonymous (not verified) on Mon, 03/11/2019 - 15:05

What are your thoughts on the use of medical marijuana?  Urology Times"There are better ways to manage people's medical problems with drugs, especially in routine urologic care. I just don't agree with marijuana," says one ...

'Forced Swim Test' Is True Terror for the Animals Involved | PETA - PETA

Submitted by Anonymous (not verified) on Mon, 03/11/2019 - 14:59

'Forced Swim Test' Is True Terror for the Animals Involved | PETA  PETAActor Floriana Lima lends her voice to uncover the terrifying reality for animals in the cruel and misguided "forced swim test."

Pages